Showing 61 - 80 results of 141 for search '"ImmunoTargets and Therapy"', query time: 0.20s Refine Results
  1. 61
    Characterizing CD8+ TEMRA Cells in CP/CPPS Patients: Insights from Targeted Single-Cell Transcriptomic and Functional Investigations

    Characterizing CD8+ TEMRA Cells in CP/CPPS Patients: Insights from Targeted Single-Cell Transcriptomic and Functional Investigations by Zhang F, Ge Q, Meng J, Chen J, Liang C, Zhang M

    Published 2024-02-01
    “…ImmunoTargets and Therapy…”
    Get full text
    Article
  2. 62
    Extended-Release Tofacitinib Therapy for a MDA5 Antibody-Positive Amyopathic Dermatomyositis Patient with Early-Stage Interstitial Lung Disease

    Extended-Release Tofacitinib Therapy for a MDA5 Antibody-Positive Amyopathic Dermatomyositis Patient with Early-Stage Interstitial Lung Disease by Wang CR, Lin WC, Wong TW

    Published 2023-12-01
    “…ImmunoTargets and Therapy…”
    Get full text
    Article
  3. 63
    Immunotherapeutic and Targeted Approaches in Multiple Myeloma

    Immunotherapeutic and Targeted Approaches in Multiple Myeloma by Nadeem O, Tai YT, Anderson KC

    Published 2020-10-01
    “…ImmunoTargets and Therapy…”
    Get full text
    Article
  4. 64
    The current status of immunobased therapies for metastatic renal-cell carcinoma

    The current status of immunobased therapies for metastatic renal-cell carcinoma by Sathianathen NJ, Krishna S, Anderson JK, Weight CJ, Gupta S, Konety BR, Griffith TS

    Published 2017-12-01
    “…ImmunoTargets and Therapy…”
    Get full text
    Article
  5. 65
    The Role of IL-17 Cytokines in Psoriasis

    The Role of IL-17 Cytokines in Psoriasis by Mosca M, Hong J, Hadeler E, Hakimi M, Liao W, Bhutani T

    Published 2021-11-01
    “…ImmunoTargets and Therapy…”
    Get full text
    Article
  6. 66
    Antigen-based immunotherapy for autoimmune disease: current status

    Antigen-based immunotherapy for autoimmune disease: current status by Hirsch DL, Ponda P

    Published 2014-12-01
    “…ImmunoTargets and Therapy…”
    Get full text
    Article
  7. 67
    Factors Associated with Adherence to Immunosuppressive Therapy and Barriers in Asian Kidney Transplant Recipients [Corrigendum]

    Factors Associated with Adherence to Immunosuppressive Therapy and Barriers in Asian Kidney Transplant Recipients [Corrigendum] by Ganjali R, Ghorban Sabbagh M, Nazemiyan F, Mamdouhi F, Badiee Aval S, Taherzadeh Z, Heshmati Nabavi F, Golmakani R, Tohidinezhad F, Eslami S

    Published 2020-09-01
    “…ImmunoTargets and Therapy…”
    Get full text
    Article
  8. 68
    Novel Immunotherapies for Myasthenia Gravis

    Novel Immunotherapies for Myasthenia Gravis by Nair SS, Jacob S

    Published 2023-04-01
    “…ImmunoTargets and Therapy…”
    Get full text
    Article
  9. 69
    Bruton’s Tyrosine Kinase Inhibitors: A New Therapeutic Target for the Treatment of SLE?

    Bruton’s Tyrosine Kinase Inhibitors: A New Therapeutic Target for the Treatment of SLE? by Lorenzo-Vizcaya A, Fasano S, Isenberg DA

    Published 2020-06-01
    “…ImmunoTargets and Therapy…”
    Get full text
    Article
  10. 70
    B cell receptor pathway in chronic lymphocytic leukemia: specific role of CC-292

    B cell receptor pathway in chronic lymphocytic leukemia: specific role of CC-292 by Arnason JE, Brown JR

    Published 2014-01-01
    “…ImmunoTargets and Therapy…”
    Get full text
    Article
  11. 71
    Emerging roles for HMGB1 protein in immunity, inflammation, and cancer

    Emerging roles for HMGB1 protein in immunity, inflammation, and cancer by Martinotti S, Patrone M, Ranzato E

    Published 2015-05-01
    “…ImmunoTargets and Therapy…”
    Get full text
    Article
  12. 72
    Chronic Inflammatory Demyelinating Polyradiculoneuropathy: Current Therapeutic Approaches and Future Outlooks

    Chronic Inflammatory Demyelinating Polyradiculoneuropathy: Current Therapeutic Approaches and Future Outlooks by Rajabally YA

    Published 2024-02-01
    “…ImmunoTargets and Therapy…”
    Get full text
    Article
  13. 73
    Cannabis and Autoimmunity: Possible Mechanisms of Action

    Cannabis and Autoimmunity: Possible Mechanisms of Action by Giorgi V, Marotto D, Batticciotto A, Atzeni F, Bongiovanni S, Sarzi-Puttini P

    Published 2021-07-01
    “…ImmunoTargets and Therapy…”
    Get full text
    Article
  14. 74
    Hyaluronidase facilitated subcutaneous immunoglobulin in primary immunodeficiency

    Hyaluronidase facilitated subcutaneous immunoglobulin in primary immunodeficiency by Jolles S

    Published 2013-09-01
    “…ImmunoTargets and Therapy…”
    Get full text
    Article
  15. 75
    Towards Early Diagnosis of Mixed Connective Tissue Disease: Updated Perspectives

    Towards Early Diagnosis of Mixed Connective Tissue Disease: Updated Perspectives by Ferrara CA, La Rocca G, Ielo G, Libra A, Sambataro G

    Published 2023-07-01
    “…ImmunoTargets and Therapy…”
    Get full text
    Article
  16. 76
    Soluble IL-7Rα/sCD127 in Health, Disease, and Its Potential Role as a Therapeutic Agent

    Soluble IL-7Rα/sCD127 in Health, Disease, and Its Potential Role as a Therapeutic Agent by Barros PO, Berthoud TK, Aloufi N, Angel JB

    Published 2021-03-01
    “…ImmunoTargets and Therapy…”
    Get full text
    Article
  17. 77
    B-Cell Targeted Treatments for Neuromyelitis Optica Spectrum Disorder: A Focus on CD19 and CD20

    B-Cell Targeted Treatments for Neuromyelitis Optica Spectrum Disorder: A Focus on CD19 and CD20 by Levy M, Mealy MA

    Published 2021-08-01
    “…ImmunoTargets and Therapy…”
    Get full text
    Article
  18. 78
    Place in therapy of rituximab in the treatment of granulomatosis with polyangiitis and microscopic polyangiitis

    Place in therapy of rituximab in the treatment of granulomatosis with polyangiitis and microscopic polyangiitis by Shah S, Geetha D

    Published 2015-08-01
    “…ImmunoTargets and Therapy…”
    Get full text
    Article
  19. 79
    The hygiene hypothesis: current perspectives and future therapies

    The hygiene hypothesis: current perspectives and future therapies by Stiemsma LT, Reynolds LA, Turvey SE, Finlay BB

    Published 2015-07-01
    “…ImmunoTargets and Therapy…”
    Get full text
    Article
  20. 80
    Targeting innate immunity to downmodulate adaptive immunity and reverse type 1 diabetes

    Targeting innate immunity to downmodulate adaptive immunity and reverse type 1 diabetes by Itoh A, Ridgway WM

    Published 2017-05-01
    “…ImmunoTargets and Therapy…”
    Get full text
    Article

Search Tools: